Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $2.4 Million - $3.95 Million
23,700 New
23,700 $2.81 Million
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $272,774 - $507,002
-2,157 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $487,093 - $794,876
2,157 New
2,157 $548,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Mbb Public Markets I LLC Portfolio

Follow Mbb Public Markets I LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mbb Public Markets I LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mbb Public Markets I LLC with notifications on news.